Noriko Ammerman

6PUBLICATIONS
7CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 12, 2024
New Therapies for Highly Sensitized Patients on the Waiting List.

Ashley Vo, Noriko Ammerman, Stanley C Jordan

|Dec 01, 2022
Importance of IL-6 inhibition in prevention and treatment of antibody-mediated rejection in kidney allografts.

Stanley C Jordan, Noriko Ammerman, Edmund Huang

|May 06, 2022
Intravenous immunoglobulin contains high-titer neutralizing IgG antibodies to SARS-CoV-2.

Stanley C Jordan, Anders Berg, Bongha Shin

|Dec 15, 2021
Clazakizumab for desensitization in highly sensitized patients awaiting transplantation.

Ashley A Vo, Edmund Huang, Noriko Ammerman

|Jun 16, 2020
The role of novel therapeutic approaches for prevention of allosensitization and antibody-mediated rejection.

Stanley C Jordan, Noriko Ammerman, Jua Choi

|Apr 18, 2020
Intravenous immunoglobulin significantly reduces exposure of concomitantly administered anti-C5 monoclonal antibody tesidolumab.

Stanley C Jordan, Klaus Kucher, Morten Bagger

Pageof 1

Frequent Collaborators

5 joint publications

Stanley C Jordan

4 joint publications

Ashley Vo

2 joint publications

Edmund Huang

1 joint publications

Mark Haas